Mechanisms of Fusion-Driven Oncogenesis in Childhood Cancers (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-23-036 from the NIH Guide for Grants and Contracts. NCI is forming the Targeting Fusion Oncoproteins in Childhood Cancers (TFCC) Network to advance our understanding of the mechanisms of action of fusion oncoproteins in pediatric cancers and to apply novel chemical strategies for developing targeted therapeutic approaches. This RFA will use the U01 mechanism to solicit applications focused on molecular mechanisms by which fusion oncoproteins drive pediatric cancers with the goals of better understanding the biology of these cancers and identifying potential drug targets or critical dependencie...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 17, 2023 Category: Research Source Type: funding
Notice of Correction to Award Budget in RFA-CA-23-027 "Advancing Cancer Control Equity Research through Transformative Solutions Coordination Center (U24 Clinical Trial Optional)"
Notice NOT-CA-23-077 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 10, 2023 Category: Research Source Type: funding
Pre-Application Webinar for Advancing Cancer Control Equity Research through Transformative Solutions RFAs: RFA-CA-23-026 and RFA-CA-23-027
Notice NOT-CA-23-076 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 29, 2023 Category: Research Source Type: funding
Notice of Correction to NOT-CA-23-071: Notice of Special Interest (NOSI): Administrative Supplements for Enhancing Recruitment and Retention of Diverse Populations to Cancer Screening, Cancer Prevention and Symptom Management Clinical Trials
Notice NOT-CA-23-075 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 28, 2023 Category: Research Source Type: funding
Advancing Cancer Control Equity Research through Transformative Solutions Coordination Center (U24 Clinical Trial Optional)
Funding Opportunity RFA-CA-23-027 from the NIH Guide for Grants and Contracts. This notice of funding opportunity (NOFO) invites grant applications for a Coordination Center to support four research centers that address the impact of social determinants of health (SDOH) on adverse cancer control outcomes. The Coordination Center will 1) lead efforts to manage and share consortium-wide data; 2) connect research Centers with capacity building and training opportunities and disseminate synthesized research products; 3) stimulate and coordinate consortium collaborative activities, and 4) evaluate the impact of the consortiu...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 28, 2023 Category: Research Source Type: funding
Advancing Cancer Control Equity Research Through Transformative Solutions (U19 Clinical Trial Optional)
Funding Opportunity RFA-CA-23-026 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity is to advance cancer control equity research by stimulating community-engaged, multilevel research interventions that address the impact of social determinants of health on adverse cancer outcomes. Applicants will 1) develop interventions that target the multilevel pathways by which social determinants of health impact adverse cancer outcomes; 2) develop methods, measures, and assess community-level SDOH, community engagement, and cancer control equity processes and outcomes; and 3) build capacity among...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 28, 2023 Category: Research Source Type: funding
Notice of Pre-Application Webinar for PAR-23-155: Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
Notice NOT-CA-23-073 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 23, 2023 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Administrative Supplements for Enhancing Recruitment and Retention of Diverse Populations to Cancer Screening, Cancer Prevention and Symptom Management Clinical Trials
Notice NOT-CA-23-071 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 22, 2023 Category: Research Source Type: funding
Notice of Correction to Agency Routing Identifier for NOT-CA-23-060 "Notice of Special Interest (NOSI): RNA Modifications in Cancer Biology"
Notice NOT-CA-23-074 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 21, 2023 Category: Research Source Type: funding
Simultaneous and Synergistic Multi-Target Validation for Alzheimers Disease-Related Dementias (R61/R33 Clinical Trial not allowed)
Funding Opportunity PAR-23-195 from the NIH Guide for Grants and Contracts. The ultimate goal is to develop multi-target disease-modifying therapeutics based on an appreciation of the complex interaction of pathways, cells, circuits, systems or pathologies that are present in complex AD/ADRD diagnoses. Such therapeutics could be a single drug or biologic targeting multiple pathways, cell, circuits, systems or pathologies, or could be a combination of therapies. While hundreds of possible targets have been suggested for AD alone, theres a need to better understand how multiple targets might interact in a synergistic way ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 20, 2023 Category: Research Source Type: funding
The Blood and Marrow Transplant Clinical Trials Network - Data Coordinating Center (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-HL-24-011 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to advance hematopoietic cell transplantation (HCT) for all patients, but particularly for patients with rare and difficult to treat non-malignant blood diseases and hematological malignancies. This will be accomplished by supporting a clinical trials network to evaluate novel cell therapy (CT) and HCT approaches. A Data Coordinating Center (DCC) and core clinical sites will be supported by funds requested as part of this initiative, as well as a limited number of trials. Additional studies and trials will be...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 20, 2023 Category: Research Source Type: funding
The Blood and Marrow Transplant Clinical Trials Network - Core Clinical Centers (UG1 Clinical Trial Optional)
Funding Opportunity RFA-HL-24-010 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to advance hematopoietic cell transplantation (HCT) for all patients, but particularly for patients with rare and difficult to treat non-malignant blood diseases and hematological malignancies. This will be accomplished by supporting a clinical trials network to evaluate novel cell therapy (CT) and HCT approaches. A Data Coordinating Center (DCC) and core clinical sites will be supported by funds requested as part of this initiative, as well as a limited number of trials. Additional studies and trials will be...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 20, 2023 Category: Research Source Type: funding
Notice of Correction to Key Dates in RFA-CA-23-015, Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
Notice NOT-CA-23-072 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 16, 2023 Category: Research Source Type: funding
Leveraging Social Networks to Promote Widespread Individual Behavior Change (R01 and R34 Clinical Trial Optional)
Funding for planning activities and research to develop social network interventions to promote health across the lifespan, especially in populations in which they are currently largely underdeveloped and untested. Rural and tribal populations are research interests, among others. Geographic coverage: Nationwide -- National Cancer Institute, National Institute on Aging, National Institutes of Health, U.S. Department of Health and Human Services (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - June 13, 2023 Category: American Health Source Type: funding
Notice of Special Interest (NOSI): Research on HIV-associated Malignancies
Notice NOT-CA-23-070 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 8, 2023 Category: Research Source Type: funding
